http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-071239-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031 |
| filingDate | 2008-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-071239-A1 |
| titleOfInvention | MICROSPHERES THAT HAVE A NUCLEUS / COATING STRUCTURE THAT INCLUDE ARIPIPRAZOL AND USE |
| abstract | Microspheres having a core / coating structure and a spherical shape, where (a) the core comprises solid phase aripiprazole, and (b) the coating covers all or most of the core surface, and comprises a biodegradable polymer; a process for producing the microspheres, and an aqueous injectable suspension formulation containing the microspheres. Claim 15: A method for treating schizophrenia, characterized in that it comprises administering an aqueous injectable suspension formulation according to claim 7 to a patient in need of said treatment. |
| priorityDate | 2007-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492710 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60795 |
Total number of triples: 15.